Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × amivantamab × 30 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 43 Specimen Handling 36 Biopsy 32 Magnetic Resonance Spectroscopy 31 Carboplatin 28 Cisplatin 27 Cyclophosphamide 24 Paclitaxel 21 Nivolumab 19 Gemcitabine 18 Doxorubicin 18 durvalumab 16 Radiotherapy 16 Radiation 15 Prednisone 15 Rituximab 14 olaparib 13 Pemetrexed 13 Ipilimumab 13 Lenalidomide 12 fludarabine 11 Radiotherapy, Intensity-Modulated 11 Fulvestrant 11 Fluorouracil 11 Disulfides 11 Bevacizumab 11 Vincristine 10 Temozolomide 10 Immunoglobulin G 10 Docetaxel 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04538664 2026-02-25

PAPILLON

Janssen Research & Development, LLC

Phase 3 Active not recruiting

308 enrolled 12 charts 1 FDA

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡